Jump to content

Category:Antiparkinsonian agents

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Graham87 (talk | contribs) at 14:44, 26 November 2023 (Reverted edits by GregZak (talk) to last version by Aoziwe). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Antiparkinson agents (N04)

DA precursors	Levodopa^# (+benserazide) Melevodopa
DA receptor agonists	Ergoline: Bromocriptine Cabergoline Dihydroergocryptine Lisuride Pergolide Non-ergoline: Apomorphine Piribedil Pramipexole Ropinirole Rotigotine Talipexole
MAO-B inhibitors	Rasagiline Safinamide Selegiline
COMT inhibitors	Entacapone Opicapone Tolcapone
AAAD inhibitors	Benserazide (+levodopa) Carbidopa^#

Anticholinergics

Others

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This category reflects the organization of Anatomical Therapeutic Chemical Classification System code N04.
Generally, drugs outlined within the ATC code N04 should be included in this category.
Please see WP:PHARM:CAT for more information.

Wikimedia Commons has media related to Antiparkinsonian agents.

These agents are used to treat Parkinson's disease.

Anti-Parkinsonian Drugs include:

Anticholinergic Agents; COMT Inhibitors; Dopamine Agonists; Levodopa; MAO-B Inhibitors

Subcategories

This category has the following 3 subcategories, out of 3 total.

A

Aromatic L-amino acid decarboxylase inhibitors‎ (7 P)

C

Catechol-O-methyltransferase inhibitors‎ (9 P)

D

Dopamine agonists‎ (5 C, 54 P)

Pages in category "Antiparkinsonian agents"

The following 24 pages are in this category, out of 24 total. This list may not reflect recent changes.

A

Amantadine

B

C

D

L-DOPA

E

L

M

P

R

Rasagiline

S

Selegiline

T

Retrieved from "https://en.wikipedia.org/w/index.php?title=Category:Antiparkinsonian_agents&oldid=1186953404"

Hidden category:

Commons category link is on Wikidata